Ethane;4-[2-fluoro-4-(5-methyl-2-oxo-1,3-oxazolidin-3-yl)phenyl]cyclohepta-2,4,6-triene-1-carbaldehyde
C20H22FNO3 — CID 143007095
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethane;4-[2-fluoro-4-(5-methyl-2-oxo-1,3-oxazolidin-3-yl)phenyl]cyclohepta-2,4,6-triene-1-carbaldehyde
Ethane;4-[2-fluoro-4-(5-methyl-2-oxo-1,3-oxazolidin-3-yl)phenyl]cyclohepta-2,4,6-triene-1-carbaldehyde (PubChem CID 143007095) has the molecular formula C20H22FNO3 and a molecular weight of 343.40 g/mol. Its IUPAC name is ethane;4-[2-fluoro-4-(5-methyl-2-oxo-1,3-oxazolidin-3-yl)phenyl]cyclohepta-2,4,6-triene-1-carbaldehyde.
Molecular Properties
| Compound Name | Ethane;4-[2-fluoro-4-(5-methyl-2-oxo-1,3-oxazolidin-3-yl)phenyl]cyclohepta-2,4,6-triene-1-carbaldehyde |
|---|---|
| PubChem CID | 143007095 |
| Molecular Formula | C20H22FNO3 |
| Molecular Weight | 343.40 g/mol |
| Exact Mass | 343.16 |
| IUPAC Name | ethane;4-[2-fluoro-4-(5-methyl-2-oxo-1,3-oxazolidin-3-yl)phenyl]cyclohepta-2,4,6-triene-1-carbaldehyde |
| SMILES | CC.CC1CN(c2ccc(C3=CC=CC(C=O)C=C3)c(F)c2)C(=O)O1 |
| InChI | InChI=1S/C18H16FNO3.C2H6/c1-12-10-20(18(22)23-12)15-7-8-16(17(19)9-15)14-4-2-3-13(11-21)5-6-14;1-2/h2-9,11-13H,10H2,1H3;1-2H3 |
| InChIKey | MHEFPQPKHBJIQJ-UHFFFAOYSA-N |
| XLogP | 4.52 |
| TPSA | 46.61 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 343.40 |
| LogP ≤ 5 | 4.52 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143007095 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.